Skip to main content

Table 2 Comparison of groups according to maternal cardiac complications

From: Predictors of maternal and neonatal complications in women with severe valvular heart disease during pregnancy in Tunisia: a retrospective cohort study

 

MCC+(n = 37)

MCC-(n = 23)

p

Mean Age (SD)

33.4 ± 5.5

31.17 ± 5.4

0.13

Rural origin (%)

22(59.5)

23(30.4)

0.029

Low educational level (%)

26(70.3)

8(34.8)

0.007

Parity

2.45 ± 1.21

2.21 ± 1.16

0.038

Gravidity

3.16 ± 1.81

2.21 ± 1.16

0.01

Nulliparity (%)

11 (29.7)

10(43.5)

0.27

Unwanted pregnancy (%)

21(56.7)

9(39.1)

0.184

Unattended pregnancy (%)

29 (79.3)

20(87)

0.31

Hypertension before pregnancy (%)

3(8.1)

2(8.6)

0.64

Valve disease revealed during pregnancy (%)

23(62.2)

8(34.8)

0.039

NYHA≥2 (%)

21(56.8)

10(43.5)

0.31

Atrial fibrillation

18(48.6)

5(21.7)

0.037

Multiple valve disease (%)

19(51.4)

9(39.1)

0.35

Severe MS (%)

32(86.5)

11(47.8)

0.001

Severe AS (%)

5(13.5)

5(21.7)

0.31

Severe MR (%)

4(10.8)

6(26.1)

0.12

Severe AR (%)

1(2.7)

1(4.3)

0.62

LVEF (%)

57.4 ± 7.2

61.13 ± 2.2

0.011

PASP (mmHg)

57.29 ± 15.8

40.39 ± 9.7

< 0.001

LA diameter (mm)

52.72 ± 7.35

47.39 ± 6.04

0.005

Anemia ((%)

24 (64.9)

12 (52.2)

0.32

  1. AS Aortic stenosis, AR Aortic regurgitation, LVEF Left ventricle ejection fraction, LA Left atrium, MCC maternal cardiac complications, MS Mitral stenosis, MR Mitral regurgitation, NYHA New York Heart Association, PASP Mean pulmonary arterial systolic pressure